Home › Targets › CD5

CD5 (1 companies · 2 programs)

Companies with an active program directed at CD5.

Artiva Biotherapeutics, Inc. ARTV

AB-205 — T-Cell Lymphoma
AB-205 — T-Cell Acute Lymphoblastic Leukemia